BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15563182)

  • 1. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere.
    Wang XJ; Xu B; Mullins AB; Neiler FK; Etzkorn FA
    J Am Chem Soc; 2004 Dec; 126(47):15533-42. PubMed ID: 15563182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reduced-amide inhibitor of Pin1 binds in a conformation resembling a twisted-amide transition state.
    Xu GG; Zhang Y; Mercedes-Camacho AY; Etzkorn FA
    Biochemistry; 2011 Nov; 50(44):9545-50. PubMed ID: 21980916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate-based design of reversible Pin1 inhibitors.
    Zhang Y; Füssel S; Reimer U; Schutkowski M; Fischer G
    Biochemistry; 2002 Oct; 41(39):11868-77. PubMed ID: 12269831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition.
    Schutkowski M; Bernhardt A; Zhou XZ; Shen M; Reimer U; Rahfeld JU; Lu KP; Fischer G
    Biochemistry; 1998 Apr; 37(16):5566-75. PubMed ID: 9548941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.
    Ieda N; Itoh K; Inoue Y; Izumiya Y; Kawaguchi M; Miyata N; Nakagawa H
    Bioorg Med Chem Lett; 2019 Feb; 29(3):353-356. PubMed ID: 30585173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent advances in the study of pin1 and its inhibitors].
    Zhang CJ; Zhang ZH; Xu BL; Wang YL
    Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamics of phosphopeptide binding to the human peptidyl prolyl cis/trans isomerase Pin1.
    Daum S; Fanghänel J; Wildemann D; Schiene-Fischer C
    Biochemistry; 2006 Oct; 45(39):12125-35. PubMed ID: 17002312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereospecific gating of functional motions in Pin1.
    Namanja AT; Wang XJ; Xu B; Mercedes-Camacho AY; Wilson KA; Etzkorn FA; Peng JW
    Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12289-94. PubMed ID: 21746900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Pin1 inhibitory activity of thiazole derivatives.
    Zhao H; Cui G; Jin J; Chen X; Xu B
    Bioorg Med Chem; 2016 Nov; 24(22):5911-5920. PubMed ID: 27692510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Design, synthesis and biological evaluation of novel diaryl ethers bearing a pyrimidine motif as human Pin1 inhibitors].
    Xi YY; Jin J; Sun Y; Chen XG; Song HR; Xu BL
    Yao Xue Xue Bao; 2013 Aug; 48(8):1266-72. PubMed ID: 24187834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis.
    Rippmann JF; Hobbie S; Daiber C; Guilliard B; Bauer M; Birk J; Nar H; Garin-Chesa P; Rettig WJ; Schnapp A
    Cell Growth Differ; 2000 Jul; 11(7):409-16. PubMed ID: 10939594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformation-directed catalysis and coupled enzyme-substrate dynamics in Pin1 phosphorylation-dependent cis-trans isomerase.
    Velazquez HA; Hamelberg D
    J Phys Chem B; 2013 Oct; 117(39):11509-17. PubMed ID: 23980573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptidyl prolyl isomerase Pin1-inhibitory activity of D-glutamic and D-aspartic acid derivatives bearing a cyclic aliphatic amine moiety.
    Nakagawa H; Seike S; Sugimoto M; Ieda N; Kawaguchi M; Suzuki T; Miyata N
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5619-24. PubMed ID: 26508545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1.
    Liu T; Liu Y; Kao HY; Pei D
    J Med Chem; 2010 Mar; 53(6):2494-501. PubMed ID: 20180533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of prolyl isomerase pin1 in pathogenesis of diseases and remedy for the diseases from natural products.
    Takahashi K; Shimizu T; Kosaka K; Hidaka M; Uchida C; Uchida T
    Curr Drug Targets; 2014; 15(10):973-81. PubMed ID: 25182609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of the phospho-dependent prolyl cis/trans isomerase Pin1.
    Lippens G; Landrieu I; Smet C
    FEBS J; 2007 Oct; 274(20):5211-22. PubMed ID: 17892493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.
    Mori T; Hidaka M; Lin YC; Yoshizawa I; Okabe T; Egashira S; Kojima H; Nagano T; Koketsu M; Takamiya M; Uchida T
    Biochem Biophys Res Commun; 2011 Mar; 406(3):439-43. PubMed ID: 21333629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design of novel human Pin1 inhibitors (I).
    Guo C; Hou X; Dong L; Dagostino E; Greasley S; Ferre R; Marakovits J; Johnson MC; Matthews D; Mroczkowski B; Parge H; Vanarsdale T; Popoff I; Piraino J; Margosiak S; Thomson J; Los G; Murray BW
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5613-6. PubMed ID: 19729306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1.
    Tatara Y; Lin YC; Bamba Y; Mori T; Uchida T
    Biochem Biophys Res Commun; 2009 Jul; 384(3):394-8. PubMed ID: 19422802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of pyrimidine derivatives as novel human Pin1 inhibitors.
    Cui G; Jin J; Chen H; Cao R; Chen X; Xu B
    Bioorg Med Chem; 2018 May; 26(8):2186-2197. PubMed ID: 29576270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.